Sensor Technology Aims to Improve Medication Adherence
Sensors and devices being developed by nGageIT Digital Health Solutions can track patient use of oral solid-dosage or injectable drugs.
Article updated Sept. 5, 2019
Nano-enabled technology and sensor platforms from nGageIT Digital Health Solutions will allow verification that medications are ingested correctly, and on schedule, using a smart phone, said the company in a March 2018 press release. Technologies include a nanoparticle that can be added to oral solid-dosage drug coatings.
The sensor technologies monitor when patients take either oral medications. These data are automatically uploaded to the cloud through the patient’s smart phone and can be tracked in real-time by healthcare providers and in clinical trials, which will lead to better compliance with medical advice and medical device use. Patients can automate complex dosing schedules, and physicians can use medication usage data to precisely customize therapy.
The company’s NanoSmart oral encoding platform includes encoding particles and the NanoSmart Biosensor. The biosensor detects digitally encoded nanoparticles from the patient’s breath using a detection device called the Noz. The NanoSmart encoding particles can be integrated into current oral dosage coatings.
Source: nGageIT Digital Health Solutions
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
